In dysregulated signaling pathways, such as TGF-β, Notch, and PD-L1, stromal-derived factor-1 (SDF-1)/CXCR4 signaling pathways play key roles in pancreatic cancer progression and treatment resistance. The gene discussed is TGFB1; the disease is pancreatic neoplasm.